Document:

FORM OF SUBSCRIPTION AGREEMENT

FORM OF SUBSCRIPTION AGREEMENT

THIS
SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into by and between BIOHEART, INC., a
Florida corporation (OTCBB: BHRT) (the “Company”), and the undersigned Investor (the "Investor”).

WHEREAS,
the Investor desires to purchase directly from the Company an aggregate number of Units (as hereinafter defined)
(collectively, the “Subscribed Units”) equal to quotient of (a) One Million, Eight Hundred Sixty-Six Thousand, Six
Hundred, Sixty-Seven Dollars (US $1,866,667) (the “Aggregate Purchase Price”) divided by (b) the Unit
Purchase Price (as hereinafter defined) upon the terms and subject to the conditions described in this agreement;

WHEREAS,
each “Unit” consists of ten (10) shares of the Company's common stock, par value $0.001 per share (the "
Common Stock") (each, a “Share”) and one (1) warrant to purchase five (5) shares of the Common Stock
(the “Warrant” and, collectively with the Units and the shares issuable upon the exercise of the Warrant, the
“Securities”);

WHEREAS, the purchase price of each
Subscribed Unit to be purchased by the Investor pursuant to this Agreement shall be an amount (the “
Unit Purchase Price”) equal to the
greater of:

(a)

One
and 50/100 Dollars (US $1.50); or

(b)

the
product of: (i) fifty percent (50%)  of the average closing price of the Common Stock, as quoted on the OTCBB for each of the
five (5) trading days immediately preceding the First Installment Payment Date
 (as defined below); multiplied by (ii) ten (10).  

WHEREAS,
each Warrant shall be evidenced by the form of Warrant Agreement attached hereto as Exhibit A (the “Warrant Agreement”) and Each Warrant will be exercisable for five (5) shares of Common Stock at an anticipated exercise price (the
“Exercise Price”) equal to 120% of the quotient obtained by dividing the Per Unit Purchase Price by 10 (the
“Anticipated Exercise Price”) payable in cash.    

WHEREAS,
the Investor confirms that the Investor is an “Accredited Investor” as indicated in Section 4.2(i) hereof, and the
Investor hereby executes this Agreement in accordance with and subject to the terms and conditions set forth herein for the purpose
of purchasing the Units; 

NOW,
THEREFORE, for and in consideration of the premises and mutual covenants, representations, warranties and agreements set
forth herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the
parties hereto, intending to be legally bound, do hereby agree as follows:

ARTICLE I

INFORMATION

The Investor
hereby represents and warrants that it is in receipt of and, prior to signing this Agreement, has carefully read and understood the
following items (collectively, the “Materials”):

(a)

This Agreement;

(b)

The Warrant
Agreement; 

1

(c)

The Registration
Rights Agreement, attached hereto as Exhibit B (the “Registration Rights Agreement”);  

(d)

The
Company’s Annual Report on Form 10-K, as amended by Amendment No. 1 on Form 10-K/A for the each of the years ended December 31
2008 and December 31, 2009 (the “Annual Reports”); 

(e)

The
Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2010, June 30, 2010, and September 30, 2010 (the
“Quarterly Reports”); and

(f)

The
Company’s Current Reports on Form 8-K, or Form 8-K/A, including without limitation, those filed on  January 9, 2009,
January 13, 2009, January 15, 2009, January 20, 2009, January 28, 2009, February 3, 2009, February 4, 2009, February 17, 2009,
February 26, 2009, April 8, 2009, May 18, 2009, July 9, 2009, August 3, 2009, August 18, 2009, November 12, 2009, December 31, 2009,
January 6, 2010, February 5, 2010, February 17, 2010, March 31, 2010, June 24, 2010, July 9, 2010, July 21, 2010, July 22, 2010,
August 19, 2010, September 9, 2010,September 23, 2010, September 28, 2010, October 6, 2010, October 29, 2010, November 1, 2010,
November 3, 2010, December 6, 2010, December 17, 2010, December 22, 2010 and January 6, 2011 (the “Current Reports”). 

ARTICLE II

SUBSCRIPTION AND PAYMENT; CERTAIN TERMS AND PROCEDURES

Section 2.1

Upon the terms
and subject to the conditions of this Agreement: the Investor hereby subscribes for and agrees to purchase from the Company, and the
Company hereby agrees to sell to the Investor, all of the Subscribed Units at the Unit Purchase price as defined herein.  

Section 2.2

Investor shall
pay the Aggregate Purchase Price to Company, in immediately available US funds, in installments (each, an “Installment Payment”), as follows:

(a)

One Hundred Eighty-Six Thousand, Six Hundred, Sixty-Seven Dollars (US $186,667) shall be paid
on or before the date of this Agreement (the “First Installment Payment Date”) for ten percent (10%) of the Subscribed Units;  

(b)

Seven Hundred
Forty-Six Thousand, Six Hundred, Sixty-Seven Dollars (US $746,667) shall be paid on or before March 5, 2011for forty percent (40%)
of the Subscribed Units; and

(c)

Subject to Company’s receipt of all 
Required Approvals (as hereinafter defined), the remaining Nine Hundred Thirty
Three Thousand, Three Hundred, Thirty-Three Dollars (US $933,333)  shall be paid on or before April 20, 2011 for the remaining
fifty percent (50%) of the Subscribed Units.  

As used herein, “
Required Approvals” means:
all actions and approvals necessary for compliance by Company with applicable law in connection with the sale of the Securities and
the increase in authorized shares, including without limitation, the filing of Schedule 14C and the satisfaction of any related
requirements imposed by the SEC or securities laws and regulations.  The Company represents to Investor that a majority of the
Company’s shareholders has already approved, or will prior to the First Installment Payment Date approve, an increase in the
number of authorized shares of the Company’s Common Stock to enable Company to sell the Subscribed Units to the Investor upon
the terms and conditions of this Agreement.  The Company will use commercially reasonable efforts to obtain the Required
Approvals prior to the date contemplated herein for the final Installment Payment   

2

Section 2.3

On
or prior to the First Installment Payment Date, Investor shall execute and deliver to the Company, and the Company shall execute and
deliver to the Investor: the Warrant Agreement and the Registration Rights Agreement.

Section 2.4

No later than five (5) days after the Company’s receipt of each Installment Payment (each, an “Installment Payment Date”), Company shall
deliver to Investor the number of Shares included in the Units paid
for by Investor with such Installment Payment.  Notwithstanding the foregoing, Company shall not be obligated to issue and
deliver the Shares included in the Units paid for by the final Installment Payment until all Required Approvals have been obtained.
The Company’s obligation to deliver the Shares to the Investor shall be conditioned upon the Company’s receipt of the
applicable Installment Payment.  Subject to obtaining the Required Approvals, the Company will reserve the applicable number of
Shares for issuance to the Investor upon the terms of this Agreement to ensure that all of the Shares will be available to be titled
in the name of the Investor as each Installment Payment is paid by the Investor and received by the Company.

. 

ARTICLE III

REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE COMPANY

Section 3.1

The Company
hereby represents and warrants to the Investor as of the date hereof and as of each Installment Payment Date (except as set forth
herein) as follows: 

(a)

Organization, Good Standing and
Qualification.  The Company is a corporation duly organized, validly existing and in good standing under the laws of the
State of Florida and has all requisite corporate power and authority to own and operate its properties and assets and to carry on
its business as now conducted and as proposed to be conducted, as contemplated by the Materials. 

(b)

Capitalization and Voting Rights.
 As of December 31, 2010, the authorized capital of the Company consisted of (i) 5,000,000 shares of preferred stock, par value
$0.001 (the "Preferred Stock"), none of which are outstanding and (ii) 75,000,000 shares of Common Stock, of which
37,545,865 shares of Common Stock were issued and outstanding as of December 31, 2010. 
As of December 31, 2010, there were outstanding options to purchase 2,110,544 shares of Common Stock at a weighted average
exercise price of $2.78 per share and outstanding warrants to purchase 13,920,729 shares of Common Stock at a weighted average
exercise price of $1.98 per share.

(c)

Authorization.  Except for
action required in connection with the Required Approvals (as defined in Section 2.2 above), all corporate action on the part of the
Company, its officers, directors and shareholders necessary for the authorization, execution and delivery of this Agreement, the
Warrant Agreement and the Registration Rights Agreement, the performance of all obligations of the Company hereunder and thereunder,
and the authorization, issuance, sale and delivery of the Securities has been taken or will be taken prior to the First Installment
Payment Date, and this Agreement, the Warrant Agreement and the Registration Rights Agreement constitute the valid and legally
binding obligation of the Company, enforceable in accordance with their respective terms, except (i) as limited by applicable
bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of creditors’
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other
equitable remedies, and (iii) to the extent any indemnification provisions or agreements therein may be limited by applicable
United States federal or state securities laws.

3

(d)

Valid Issuance.  The Shares
when issued and paid for in compliance with the provisions of this Agreement will be duly authorized and validly issued, fully paid,
non-assessable, and, assuming that the representations and warranties of the Investor made herein are true, complete and correct at
the time of issuance, issued in compliance with United States federal securities laws.  The shares underlying the Warrant when
issued and paid for in compliance with the provisions of this Agreement and the Warrant Agreement will be duly authorized and
validly issued, fully paid, non-assessable, and, assuming that the representations and warranties of the Investor made herein are
true, complete and correct at the time of issuance, issued in compliance with federal securities laws.  

(e)

Compliance with Charter Documents.
 Subject to obtaining the Required Approvals and the filing of the Articles of Amendment that have been or will be approved by
a majority of the shareholders of Company for the purpose of increasing the number of authorized shares of Common Stock, neither the
execution and delivery of, nor the consummation of any transaction or execution of any instrument contemplated by, this Agreement,
nor the issuance of the Securities has constituted or resulted in, or will constitute or result in, a default under or breach or
violation of any term or provision of the Company’s Articles of Incorporation or Bylaws.

ARTICLE IV

REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE INVESTOR

As an inducement
to the Company to enter into this Agreement, the Investor hereby represents and warrants to and agrees with the Company as of the
date hereof and as of each Installment Payment Date (except as set forth herein) as follows:

Section 4.1

Authorization;
Validity; No Conflict; Binding Effect.

(a)

The Investor has the full power
and authority to execute and deliver this Agreement, the Warrant Agreement and the Registration Rights Agreement, to perform all of
its obligations hereunder and thereunder, and to purchase, acquire and accept delivery of the Securities purchased hereunder. 

(b)

The execution and delivery by the
Investor of this Agreement, the Warrant Agreement and the Registration Rights Agreement, the performance by the Investor of its
obligations hereunder and thereunder, and the purchase, acquisition and acceptance of delivery of the Securities by the Investor
have been duly and validly authorized by all requisite corporate or other action on the part of the Investor. 

(c)

Each of this
Agreement, the Warrant Agreement and the Registration Rights Agreement has been duly executed and delivered by the Investor and
constitutes the legal, valid and binding obligation of the Investor, enforceable in accordance with its terms except (i) as may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting creditors'
rights generally, (ii) as may be limited by laws relating to the availability of specific performance, injunctive relief, or
other equitable remedies, and (iii) to the extent any indemnification provisions or agreements therein may be limited by
applicable United States federal or state securities laws.  Investor has not previously traded in any of the securities of the
Company.

Section
4.2

Investment Representations, Warranties and Covenants.

(a)

The Investor is familiar with and
understands (i) the current and proposed business of the Company and (ii) that the Company is a development stage corporation with
no profitability to date. The Investor has carefully considered and has, to the extent the Investor believes such discussion
necessary, discussed with the Investor’s professional legal, tax, accounting and financial advisers the suitability of an 

4

investment in the Securities for the Investor’s
particular tax and financial situation and has determined that the Units being subscribed for are a suitable investment for the
Investor.

(b)

The Investor acknowledges that (i)
the Investor and the Investor’s attorney, accountant or other advisor(s) have had the right to request copies of any documents,
records and books pertaining to this investment and (ii) such documents, records, and books which the Investor or such other persons
have requested have been made available for inspection by such persons.   

(c)

The Investor has had a reasonable
opportunity to ask questions of and receive answers from a person or persons acting on behalf of the Company concerning this
purchase of Securities and all such questions have been answered to the Investor’s full satisfaction.

(d)

The Investor believes that he, she
or it has received all the information that he, she or it considers necessary or appropriate for making an investment decision with
respect to the Securities, and that such Investor has had an opportunity to ask questions and receive answers from the Company and
its management regarding, the terms and conditions of this Agreement, and the business, industry, management, technology,
properties, financial condition, results of operations and prospects of the Company and to obtain additional information necessary
to verify the accuracy of any information furnished to such Investor or to which such Investor had access.  Other than for the
representations and warranties made by the Company in this Agreement, the Investor is not relying upon any other information,
representation or warranty by the Company or any of its agents, including any brokers and finders, in determining to invest in the
Securities and is relying on the Investor’s own examination of the Company, including the merits and risks involved, in making
its investment decision.

(e)

The Investor is not subscribing
for the Securities as a result of or subsequent to any advertisement, article, notice, registration statement or other communication
published in any newspaper, magazine or similar media, filed with the Securities and Exchange Commission or broadcast over
television or radio or presented at any seminar or meeting to which the public was invited.

(f)

The Investor acknowledges that the
Investor has such knowledge and experience in business, financial, investment and banking matters (including, but not limited to,
investments in non-listed, restricted and non-registered securities of closely held, non-public companies) such that (i) the
Investor is capable of evaluating the merits, risks and advisability of an investment in the Securities, and (ii) the Investor
recognizes and appreciates the highly speculative nature of an investment in the Securities.

(g)

The Investor represents and
warrants that he or she is a sophisticated investor, has had prior experience with investments of a similar nature and that the
Investor’s knowledge and experience in business and financial matters are such that Investor is capable of evaluating the risk
of investment in the Securities and determining the suitability of the Investor’s investment in the Securities. The Investor
represents that the Investor (i) is not disproportionately invested in illiquid investments and will not become so by reason of this
investment, (ii) has adequate means of providing for the Investor’s current financial needs and contingencies and as such, does
not require the funds invested in the Securities for the Investor’s normal expenses, (iii) is able to bear the substantial
economic risks of an investment in the Securities for an indefinite period of time, (iv) has no need for liquidity in such
investment, (v) at the present time, the Investor could afford a complete loss of such investment in the Securities, and (vi) the
Investor's investment in the Securities represents less than ten percent (10%) of the portion of the Investor's assets that are
available for use in making investments in equity securities.

(h)

The Investor understands that the
Securities are being offered and sold to it, him or her in reliance upon specific exemptions from the registration requirements of
the Securities Act and applicable 

5

state exemption(s) and that the Company is relying
upon the truth and accuracy of, and the Investor's compliance with, the Investor's representations, warranties, covenants,
agreements, acknowledgments and understandings set forth herein in order to determine the availability of such exemptions and his,
her or its eligibility to acquire the Securities.

(i)

The Investor is an
“Accredited Investor” as defined in Rule 501(d) of Regulation D, promulgated by the Securities and Exchange Commission
(the "SEC") under the Securities Act, and such qualification is based on the fact that either (i) if the Investor
is an individual, the Investor (a) as of the date of this Agreement (either individually or jointly with his or her spouse) has a
net worth in excess of $1,000,000 (exclusive of the value of the primary residence, furnishings and automobiles); or (b) the
Investor had an individual income in excess of $200,000 (or joint income in excess of $300,000 with his or her spouse) for each of
the two most recent years and reasonably expects an income in excess of $200,000 (or joint income in excess of $300,000 with his or
her spouse) for the current year; or (ii) if the Investor is not an individual, the Investor (a) is a corporation, Massachusetts or
similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets
in excess of $5,000,000, or (b) is an entity in which all of the equity owners are accredited investors.

(j)

The Investor acknowledges that the
Shares herein subscribed for have not been registered under the Securities Act, or under the securities laws of any state and,
therefore, cannot be sold, transferred or otherwise disposed of unless they are either registered under the Securities Act and any
applicable state securities laws or unless exemptions from such registration are available, provided that the Investor delivers to
the Company an opinion of counsel reasonably satisfactory to the Company confirming the availability of such exemption.  The
Investor acknowledges that the Warrant herein subscribed for and the shares underlying the Warrant have not been registered under
the Securities Act, or under the securities laws of any state and, therefore, cannot be sold, transferred or otherwise disposed of
unless (x) they are either registered under the Securities Act and any applicable state securities laws or unless exemptions
from such registration are available, provided that the Investor delivers to the Company an opinion of counsel reasonably
satisfactory to the Company confirming the availability of such exemption, and (ii) the transfer is permitted by and conducted
in accordance with the Warrant Agreement. The Investor represents that the Investor is purchasing Securities for the Investor’s
own account, for investment and neither as a nominee, nor with a view to the resale or distribution thereof except in compliance
with the Securities Act and the restrictions contained in the immediately preceding sentence. The Investor has not offered or sold
any portion of the Securities being acquired nor does the Investor have any present intention, agreement, understanding or
arrangement to subdivide, sell, distribute, assign, transfer or otherwise dispose of all or any portion of the Securities to any
other person either currently or after the passage of a fixed or determinable period of time or upon
the occurrence or nonoccurrence of any predetermined event or circumstance in violation of the Securities Act. The Investor further
recognizes that, except to the extent set forth in the Registration Rights Agreement, the Company is not assuming any obligation to
register the Securities or the shares underlying the Warrant.

(k)

The Investor further covenants
that it will not make any sale, transfer or other disposition of the Securities in violation of the Securities Act, the Securities
and Exchange Act of 1934, as amended (the “Exchange Act”), the rules and regulations of the SEC promulgated
thereunder or any applicable state securities laws.

(l)

The Investor has had the
opportunity to review with its own tax advisors the federal, state and local tax consequences of the purchase of the Securities. The
Investor understands that the Investor (and not the Company) shall be responsible for his, her or its own tax liability that may
arise as a result of the purchase or sale of the Securities.

6

(m)

The Investor acknowledges that it
has had the opportunity to review the Materials and the transactions contemplated thereby with its own legal counsel. The Investor
is not relying on the Company or any of the Company’s agents for legal advice with respect to its investment in the Securities.

(n)

If this Subscription Agreement is
executed and delivered on behalf of a natural person, such person is at least 21 years of age and is purchasing the Securities
solely for such person’s own account and not for the account of any other person.

(o)

The Investor recognizes that its investment in the Securities
involves substantial risks, including loss of the entire amount of such investment, and has taken full cognizance of and understands
all of the risks related to a purchase of the Securities, including, without limitation, the risk of losing the entire investment.

(p)

The Investor has
carefully reviewed and considered the risk factors included in the Company’s Annual Reports and Quarterly Reports
(collectively, the “Risk Factors”).  THE INVESTOR HEREBY ACKNOWLEDGES AND CONFIRMS THAT THE INVESTOR HAS
CAREFULLY REVIEWED AND CONSIDERED THE RISKS AND UNCERTAINTIES DESCRIBED IN THE RISK FACTORS BEFORE MAKING AN INVESTMENT DECISION TO
PURCHASE THE SECURITIES.

(q)

THE INVESTOR ACKNOWLEDGES AND AGREES THAT THE PER UNIT
PURCHASE PRICE AT WHICH IT IS PURCHASING UNITS UNDER THIS AGREEMENT MAY BE HIGHER OR LOWER FROM THE PER UNIT PURCHASE PRICE AT WHICH
OTHER INVESTORS ACQUIRE UNITS AND THAT THE EXERCISE PRICE UNDER THE WARRANTS OTHER INVESTORS RECEIVE MAY BE LESS THAT THE EXERCISE
PRICE UNDER THE WARRANTS ISSUED AS A PART OF THE UNITS; PROVIDED THAT SUCH OTHER ACQUISITION IS EVIDENCED BY AN AGREEMENT THAT
BECAME EFFECTIVE ON A DATE AFTER THE EFFECTIVE DATE HEREOF.

Section 4.3

Legends on Stock
Certificates and Warrant.

(a)

The Investor acknowledges and
understands that the certificates representing the Shares to be purchased by such Investor and the shares issuable upon exercise of
the Warrant (the “Warrant Shares”) will bear, by imprint or endorsement, appropriate legends reflecting the status
of the Shares  and the Warrant Shares under the Securities Act and applicable state securities laws. The Investor understands
that the Shares and Warrant Shares shall bear a restrictive legend in, or substantially in, the form set forth below: 

THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR UNDER ANY STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED, SOLD, CONVEYED, PLEDGED, GIFTED, ASSIGNED, ENCUMBERED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AVAILABLE EXEMPTIONS FROM REGISTRATION FROM THE SECURITIES ACT AND THE RULES PROMULGATED THEREUNDER AND UNDER APPLICABLE STATE SECURITIES LAWS, PROVIDED THAT THE INVESTOR DELIVERS TO THE COMPANY AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY CONFIRMING THE AVAILABILITY OF SUCH EXEMPTION. INVESTORS SHOULD BE AWARE THAT THEY MAY BE 

7

REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.

(b)

The Investor agrees, that so long
as the restrictive legends described herein in this Agreement remain on the certificates representing the Shares and the Warrant
Shares, the Company may maintain appropriate "stop transfer" orders with respect to the Shares and the Warrant Shares, or
any portion thereof, on its stock books and ledger and with its registrar and transfer agent, if any.

ARTICLE V

UNDERSTANDINGS AND NOTICE TO THE INVESTOR

The Investor understands and
acknowledges as follows:

(a)

The Securities have not been
registered under the Securities Act or the securities laws of any state and are intended to be offered and sold in reliance on
exemption from the registration requirements of the Securities Act by virtue of Section 4(2) and/or other exemptions thereunder,
which is in part dependent upon the truth, completeness and accuracy of the statements made by the undersigned herein.

(b)

There is no public or other market
for the Securities and no such public or other market may ever develop. The Securities purchased by the Investor will constitute
"restricted securities" as defined in Rule 144. There can be no assurance that the undersigned will be able to sell
or dispose of the Securities. It is understood that in order not to jeopardize the sale’s exempt status under the Securities
Act, any transferee may, at a minimum, be required to fulfill the investor suitability requirements thereunder, in addition to other
requirements under the Shareholders Agreement. 

(c)

The Investor hereby acknowledges
and agrees that the Investor’s subscription and agreement to purchase the Securities hereunder is irrevocable by the Investor,
and that, except as required by applicable law (if any) with respect to investors that are residents of certain states, the Investor
is not entitled to cancel, terminate or revoke this Agreement or any agreements of the undersigned hereunder and that this Agreement
shall survive the death or disability of the undersigned and shall be binding upon and inure to the benefit of the parties and their
heirs, executors, administrators, successors, legal representatives and permitted assigns. The Investor hereby confirms that the
Investor’s state of residence is the state set forth on the Investor’s signature below. If the Investor is more than one
person, the obligations of the Investor parties hereunder shall be joint and several and the agreements, representations,
warranties, covenants and acknowledgments herein contained shall be deemed to be made by and be binding upon each such person and
his/her heirs, executors, administrators, successors, legal representatives and permitted assigns.

(d)

The Securities are subject to
restrictions on transferability and resale under applicable law and may not be transferred or resold except as permitted under the
Securities Act and applicable state securities laws, pursuant to registration or exemption therefrom and, with respect to the
Warrant and Warrant Shares, only as permitted under the Warrant Agreement. Investor should be aware that Investor may be required to
bear the financial risks of this investment for an indefinite period of time.

(e)

The Investor acknowledges that any
information provided to the Investor and/or the Investor's legal and financial advisors with respect to the sale of Securities,
including the information contained in the Materials and all additional information furnished by the Company to the Investor and/or
his advisors in connection with the Securities, is confidential and nonpublic and agrees that all such information shall be kept in
confidence by the Investor and his advisors and neither used by the Investor nor his advisors for the Investor’s or other
person’s personal benefit (other than in connection with this 

8

Subscription Agreement), nor disclosed to any other
third party for any reason; provided, however, that this obligation shall not apply to any such information that (i) is part of the
public knowledge or literature and readily accessible at the date hereof, or (ii) becomes part of the public knowledge or literature
and readily accessible by publication (except as a result of breach of this provision).

(f)

The representations, warranties,
covenants and agreements of the Investor contained herein shall be true and correct in all material respects on and as of the date
of the sale of Securities to the Investor hereunder as if made on an as of such date and shall survive the execution and delivery of
this Agreement and the Investor's purchase of the Securities.

(g)

IN MAKING AN INVESTMENT DECISION,
THE INVESTOR MUST RELY ON THE INVESTOR’S OWN EXAMINATION OF THE COMPANY AND THE TERMS OF THE PURCHASE OF THE SECURITIES,
INCLUDING THE MERITS AND RISKS INVOLVED. 

(h)

The sale of the Securities are
intended to be exempt from registration under the securities law of certain states in the United States. Persons subscribing for the
Securities must note that there are restrictions on the transfer of the Securities as stipulated herein. The Investor hereby
acknowledges that he or she has read the following notices and has taken full cognizance of and understands the notices applicable
to such Investor and the restrictions on the transfer of the Securities. 

RESIDENTS OF ALL U.S. STATES:

THE SECURITIES
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE AND ARE BEING OFFERED AND SOLD IN RELIANCE ON
EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH LAWS. THE SECURITIES HAVE NOT BEEN APPROVED OR
DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY, NOR HAVE ANY
OF THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THIS SALE OF SECURITIES. ANY REPRESENTATION TO THE CONTRARY IS
UNLAWFUL.

THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM, AND ONLY IF PERMITTED UNDER THE STOCKHOLDER AGREEMENT. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.

ARTICLE VIII

CONDITIONS TO OBLIGATIONS

Section 6.1

Conditions to Obligations of the Company.  The obligation of the Company to sell and issue the Subscribed Units
purchasable by Investor to the Investor in accordance with this Agreement 

9

is subject to, among other things,
the fulfillment on or prior to the applicable Installment Payment Date of the following conditions, any of which may be waived by
the Company:

(a)

each of the representations and
warranties of the Investor contained in this Agreement shall be true and correct in all material respects on and as of each
Installment Payment Date as if made by such Investor on and as of such date, and each of the covenants and agreements of each
Investor contained in this Agreement to be performed on or before such Installment Payment Date shall have been duly and fully
performed on or before such date, and, if requested by the Company, the Investor shall have delivered a certificate to the Company
as to the truth and accuracy of the statements in this paragraph;

(b)

no order shall have been entered
(or be in effect) by a court of competent jurisdiction which enjoins, prohibits or materially restrains the transactions
contemplated by this Agreement;

(c)

the Investor shall have delivered
to the Company,  a check or money order of federal funds wire transfer (as directed and requested by the Company prior to the
applicable Installment Payment Date), the applicable portion of the Aggregate Purchase Price payable for the Units to be purchased
by such Investor as provided hereunder.

(d)

the Investor shall have executed
and delivered to the Company the Warrant Agreement and the Registration Rights Agreement.

Section 6.2

Conditions to Obligations of the
Investor.  The obligation of the Investor to purchase the Subscribed Units purchasable by Investor upon the payment of
each Installment Payment is subject to the fulfillment on or prior to the applicable Installment Payment Date of the following
conditions, any of which may be waived by such Investor: 

(a)

each of the representations and warranties of the Company
contained in this Agreement shall be true and correct in all material respects on and as of the applicable Installment Payment Date
as if made by the Company on and as of such date, and each of the covenants and agreements of the Company contained in this
Agreement to be performed on or before the applicable Installment Payment Date shall have been duly and fully performed on or before
such date; and

(b)

The Company shall have obtained any and all consents
(including all governmental or regulatory consents, approvals or authorizations required in connection with the valid execution and
delivery of this Agreement), permits and waivers necessary or appropriate for consummation of the transactions contemplated by this
Agreement.

ARTICLE IIIII

ADDITIONAL AGREEMENTS AND PROVISIONS

Section 7.1

Certain
Covenants of the Company.

 

(a)

Until April 20, 2011, the Company shall not initiate or support any action to increase the
number of directors serving on the Company’s main Board of Directors and, subject to unforeseen circumstances outside of the
Company’s control (i.e., the death or disability of a board member), the Company will not initiate or support any change to the
composition of the Board of Directors’ Committees without the Investor’s prior consent.

(b)

Company will provide the Investor with an
estimated Use of Proceeds prior to the First Installment Payment Date; provided that the Company agrees that it will utilize not
less than sixty percent 

10

(60%) of such proceeds for research and development costs and
clinical trial costs.  The parties acknowledge and agree that a portion of the proceeds may be used to attract and hire a new
Company Chief Financial Officer.  The Company agrees that Investor, or such person as designated by the Investor, will have the
right to participate in the interviewing of, and the selection of, that new Chief Financial Officer.  Additionally, the Company
shall provide the Investor with a copy of its financial statements after the closing of each accounting month.

(c)

Until
April 20, 2011, the Company shall not issue more than Two Hundred, Fifty Thousand (250,000) shares of the Company’s Common
Stock in connection with any single transaction (other than shares that may be issued in connection with the conversion of the
existing convertible promissory note into such shares of common stock by Magna Group, LLC). 

Section

 7.2

Assignment.  Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by
any of the parties hereto without the prior written consent of the other party.

Section 7.3

Expenses.  Any legal or other fees, costs or expenses incurred in connection with the consideration, preparation, and/or
consummation of this Agreement and the transactions contemplated hereby and thereby shall be borne and paid solely by the party
incurring such fees, costs and expenses.

Section 7.4

Pronouns
and Plurals; "Person".  Whenever the context may require, any pronouns and any variations thereof used herein
shall be deemed to refer to the masculine, feminine, impersonal, singular or plural, as the identity of the person or persons may
require. As used in this Subscription Agreement, the term "person" shall mean and include an individual, entity,
corporation, trust, partnership, limited liability company or partnership, joint venture, unincorporated organization, association,
governmental authority or any agency or political subdivision thereof.

Section 7.5

Headings.  The article, section, subsection, captions, headings and other titles preceding the text of each section, subsection
or paragraph hereof are for convenience of reference only and shall not effect the construction, meaning or interpretation of this
Agreement (or of any provision hereof).

Section 7.6

Construction.  The parties acknowledge that each party has reviewed this Agreement and that any rule of construction
to the effect that ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this
Agreement (or of any provision hereof).

Section 7.7

Waiver of
Compliance; Consents.  Any failure of any party hereto to comply with any obligation, covenant, agreement or condition
herein may be waived by the other parties hereto solely by a written instrument executed by such other parties; any such written and
signed waiver, and any failure by any party to insist upon strict compliance with any obligation, covenant, agreement or condition
herein, shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure. Whenever this Agreement
requires or permits consent by or on behalf of any party hereto, such consent shall be given in writing. No waiver of any of the
provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar),
nor shall any such waiver constitute a continuing waiver unless otherwise expressly so provided.

Section 7.8

Amendment
and Modification. Except as set forth elsewhere in this Agreement, neither this Agreement nor any provision hereof shall be
amended waived, modified, supplemented, changed, discharged, terminated, revoked or canceled, except by a written instrument
mutually agreed upon and executed by all parties hereto.

11

Section 7.9

Notices.  All notices,
requests, demands, and other communications under this Agreement shall be in writing and shall be deemed to have been duly given on
the date of service if served personally on the party to whom notice is to be given, on the date of transmittal of services via
facsimile or telecopy to the party to whom notice is to be given (if receipt is orally confirmed by phone and a confirming copy
delivered thereafter in accordance with this Section), or on the fifth day after mailing if mailed to the party to whom notice is to
be given, by first class mail, registered or certified, postage prepaid, or via a nationally recognized overnight courier providing
a receipt for delivery and properly addressed to the applicable address as set forth below. Any party may change its address for
purposes of this paragraph by giving notice of the new address to each of the other parties in the manner set forth above.

(a)

If to the Company to:

Bioheart, Inc.

13794 NW 4th Street

Suite 212

Sunrise, Florida 33325

Attention: Catherine Sulawske-Guck

     COO and
Corporate Secretary

Fax:       (954) 845-9976

Phone:   (954) 835-1500

With a
copy to:

Gregory Sichenzia

Sichenzia Ross Friedman Ference LLP

61 Broadway

32nd Floor

New York, NY 10006

Fax:  ( (212) 930-9725

Phone:  (212) 930-9700

(b) If to the Investor, to the Investor’s designees
at the address set forth on the signature page hereto.

Section 7.10

Binding
Effect.  This Agreement and all the terms and provisions hereof shall be binding upon and inure to the benefit of the
parties hereto and their respective heirs, estate, legal representatives, successors and permitted assigns and are not intended and
shall not be construed so as to confer any rights or benefits upon any other person or party.

Section 7.11

Dealings
in Good Faith; Best Efforts.  Each party hereto agrees to act in good faith with respect to the other party or parties
hereto in exercising its rights and discharging its obligations under this Agreement. Each party further agrees to use its
reasonable best efforts to ensure that the purposes of this Agreement (and the related documents and agreements referred to herein)
are realized and to take such further actions or steps, and execute and deliver (and, as appropriate, file) such further documents,
certificates, instruments and agreements, as are reasonably necessary to implement the provisions of this Agreement and to
consummate the transactions contemplated by this Agreement.

Section 7.12

Governing
Law; Jurisdiction.  The validity and effect of this Agreement, and the rights and obligations of the parties hereto,
shall be enforced, governed by, and construed in all respect in accordance with the internal laws of the State of Florida (without
reference to conflict of laws 

12

provisions).  Each Party
hereby irrevocably and unconditionally (a) agrees that any Action or Proceeding, at Law or equity, arising out of or relating to
this Agreement and any other agreements or the transactions contemplated hereby and thereby shall only be brought in the state or
federal courts located in Miami-Dade County, Florida, (b) expressly submits to the personal jurisdiction and venue of such courts
for the purposes thereof and (c) waives and agrees not to raise (by way of motion, as a defense or otherwise) any and all
jurisdictional, venue and convenience objections or defenses that such party may have in such action or proceeding.  Each party
hereby irrevocably and unconditionally consents to the service of process of any of the aforementioned courts.  Nothing herein
contained shall be deemed to affect the right of any party to serve process in any manner permitted by law or commence legal
proceedings or otherwise proceed against any other party in any other jurisdiction to enforce judgments obtained in any action or
proceeding brought pursuant to this Paragraph 7.11.

Section 7.13

Severability. 

It is the
desire and intention of the parties hereto that, whenever possible, each provision of this Subscription Agreement be interpreted in
such a manner as to be effective and valid under applicable law; if, however, any provision of this Subscription Agreement is found
or held to be invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative
to the extent that it may conflict therewith and shall be deemed to be modified to conform with such statute or rule of law. Any
provision hereof that may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other
provision hereof.

Section 7.14

Entire Agreement.  This
Subscription Agreement, the Shareholders Agreement and the Warrant Agreement  and the Registration Rights Agreement constitute
the entire agreement and understanding of the parties hereto with respect to the subject matter hereof, and supersedes all prior
discussions, understandings, negotiations, agreements, representations, warranties, promises, assurances, covenants, arrangements
and communications, both written and oral, express or implied, of any and every nature between or among the parties hereto.

Section 7.15

Counterparts.  This
Subscription Agreement may be executed through the use of one or more counterparts, all of which together shall be considered one
and the same agreement, binding on all parties hereto, notwithstanding that all parties are not signatories to the same counterpart.
 

Section 7.16

Specific Performance.
 In addition to any and all other remedies that may be available at law in the event of any breach of this Agreement, each
party shall be entitled to specific performance of the agreements and obligations of the other party hereunder and to such other
injunctive or other equitable relief as may be granted by a court of competent jurisdiction.

Section 7.17

Waiver of Jury Trial.  
THE INVESTOR AND THE COMPANY HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING BASED UPON, OR
RELATED TO, THE SUBJECT MATTER OF THIS LETTER AGREEMENT. THIS WAIVER IS KNOWINGLY, INTENTIONALLY AND VOLUNTARILY MADE BY THE
INVESTOR AND THE COMPANY.

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK

INVESTOR SIGNATURE PAGE FOLLOWS]

13

PAGE INTENTIONALLY LEFT BLANK 

14

SUBSCRIPTION AGREEMENT SIGNATURE PAGE

IN WITNESS
WHEREOF, the parties hereto have executed this Agreement as of the date this Agreement is accepted by the Company as set forth
below.

TO BE COMPLETED BY INVESTOR(s)

By:/s/Ariel Quiros                

(Signature)

By: Ariel Quiros                   

(Signature)

Name: Bioheart Florida, LLC

Date:

January 23, 2011          

(Print Name of Individual or Entity)

Title:

President                

Address:

111 N.E. 1st Street, 4th Floor        

Miami, FL 33132                          

_____________________________

Telephone No.: __________________________

E-mail address: __________________________

Tax ID: 204774052                      
                  

COMPANY

BIOHEART, INC.

     /s/Mike Tomas                              

Date Subscription Accepted:    January 23, 2011 

Title:   CEO & President

Name: Mike Tomas

Address:

Bioheart, Inc.

13794 NW 4th Street, Suite 212

Sunrise, Florida 33325

15Converted by EDGARwiz

REGISTRATION RIGHTS AGREEMENT

THIS
REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into by and among BIOHEART, INC., a
Florida corporation (the “Company” or “Bioheart”), and the persons who have signed a signature
page(s) hereto (each, an "Investor” and collectively, the “Investors”).

WHEREAS,
pursuant to and in accordance with the terms of those certain Subscription Agreements, by and between the Company and each Investor
(collectively, the “Subscription Agreements”), each of the Investors have expressed a desire to purchase from the
Company, upon the terms and subject to the conditions set forth in the subject Subscription Agreement, that number of Units (the
"Units") set forth opposite such Investor’s name on the signature page to the subject Subscription Agreement,
which Units are offered to the Investors pursuant to the sale of securities (the “Sale of securities”): 

WHEREAS,
each Unit consists of ten (10) shares (the “Shares”) of the Common Stock (as defined below) and one (1) warrant to
purchase five (5) shares of the Common Stock (the “Warrant”); and

WHEREAS,
the Company and the Investors desire to enter into an agreement granting the Investors certain registration rights in connection
with their ownership of the Shares and Warrants (including the shares of the Common Stock into which such Warrants are exercisable).

NOW,
THEREFORE, in consideration of the promises and mutual agreements set forth herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

1. 

Certain Definitions. As used in this
Agreement, the following terms shall have the following respective meanings:

“Blackout Period” means,
with respect to a registration, a period, in each case commencing on the day immediately after the Company notifies the Investors
that they are required, because of the occurrence of an event of the kind described in Section 4(f) hereof, to suspend offers and
sales of Registrable Securities during which the Company, in the good faith judgment of its Board of Directors, determines (because
of the existence of, or in anticipation of, any acquisition, financing activity, or other transaction involving the Company, or the
unavailability for reasons beyond the Company’s control of any required financial statements, disclosure of information which
is in its best interest not to publicly disclose, or any other event or condition of similar significance to the Company) that the
registration and distribution of the Registrable Securities to be covered by such Registration Statement, if any, would be seriously
detrimental to the Company and its stockholders and ending on the earlier of (1) the date upon which the material non-public
information commencing the Blackout Period is disclosed to the public or ceases to be material and (2) such time as the Company
notifies the selling Holders that sales pursuant to such Registration Statement or a new or amended Registration Statement may
resume.

“Business Day” means any
day of the year, other than a Saturday, Sunday, or other day on which the Commission is required or authorized to close.

 

“Commission” means the U.
S. Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.

 

“Common Stock” means the
common stock, par value $0.001 per share, of the Company and any and all shares of capital stock or other equity securities of: (i)
the Company which are added to or exchanged or substituted for the Common Stock by reason of the declaration of any stock dividend
or 

1

stock split, the issuance of any distribution or the
reclassification, readjustment, recapitalization or other such modification of the capital structure of the Company; and (ii) any
other corporation, now or hereafter organized under the laws of any state or other governmental authority, with which the Company is
merged, which results from any consolidation or reorganization to which the Company is a party, or to which is sold all or
substantially all of the shares or assets of the Company, if immediately after such merger, consolidation, reorganization or sale,
the Company or the stockholders of the Company own equity securities having in the aggregate more than 50% of the total voting power
of such other corporation.

“Effective Date” means the
date of the final closing of the Sale of securities.

 

“Exchange Act” means the
Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder.

 

“Family Member” means (a)
with respect to any individual, such individual’s spouse, any descendants (whether natural or adopted), any trust all of the
beneficial interests of which are owned by any of such individuals or by any of such individuals together with any organization
described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended, the estate of any such individual, and any
corporation, association, partnership or limited liability company, all of the equity interests of which are owned by those above
described individuals, trusts or organizations and (b) with respect to any trust, the owners of the beneficial interests of such
trust.

 

“Holder” means each
Investor or any such Investor’s successors and Permitted Assignees who acquire rights in accordance with this Agreement with
respect to any Registrable Securities directly or indirectly from an Investor or from any Permitted Assignee.

“Majority of the Holders”
means at any time Holders representing a majority of the Registrable Securities.

 

“Permitted Assignee” means
(a) with respect to a partnership, its partners or former partners in accordance with their partnership interests, (b) with respect
to a corporation, its shareholders in accordance with their interest in the corporation, (c) with respect to a limited liability
company, its members or former members in accordance with their interest in the limited liability company, (d) with respect to an
individual, any Family Member of such party or (e) an entity that is controlled by, controls, or is under common control with a
transferor.

 

“Piggyback Registration”
means, in any registration of Common Stock referenced in Section 3(a) of this Agreement, the right of each Holder to include the
Registrable Securities of such Holder in such registration.

 

The terms “register,”
“registered,” and “registration” refer to a registration effected by preparing and filing a
registration statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such
registration statement.

 

“Registrable Common Shares”
means the Shares (and not including the Registrable Warrant Shares) but excluding (i) any Shares that have been publicly sold or are
eligible be sold under the Securities Act pursuant to Rule 144 of the Securities Act during any ninety (90) day period; (ii) any
Shares sold by a person in a transaction pursuant to a registration statement filed under the Securities Act, or (iii) any Shares
that are at the time subject to an effective registration statement under the Securities Act. 

2

“Registrable Securities”
means the Registrable Common Shares together with the Registrable Warrant Shares. 

 

“Registrable Warrant Shares” means the shares of Common Stock issued or issuable to each Investor upon exercise of the Warrants (the “Warrant
Shares”) but excluding (i) any Warrant Shares that have been publicly sold or are eligible to be sold under the Securities Act
pursuant to Rule 144 of the Securities Act during any ninety (90) day period; (ii) any Warrant Shares sold by a person in a
transaction pursuant to a registration statement filed under the Securities Act, or (iii) any Warrant Shares that are at the time
subject to an effective registration statement under the Securities Act. 

“Registration Statement”
has the meaning ascribed to such term in Section 3(a) hereof.

“Rule 145” means Rule 145
promulgated by the Commission under the Securities Act, as such rule may be amended or supplemented from time to time, or any
similar successor rule that may be promulgated by the Commission.

 

“Rule 144” means Rule 144
promulgated by the Commission under the Securities Act, as such rule may be amended or supplemented from time to time, or any
similar successor rule that may be promulgated by the Commission. 

 

“Rule 415” means Rule 415
promulgated by the Commission under the Securities Act, as such rule may be amended or supplemented from time to time, or any
similar successor rule that may be promulgated by the Commission. 

 

“Securities Act” means the
Securities Act of 1933, as amended, or any similar federal statute promulgated in replacement thereof, and the rules and regulations
of the Commission thereunder, all as the same shall be in effect at the time.

“Shares” has the meaning
ascribed to such term in the recitals of this Agreement.

“Term” has the meaning
ascribed to such term in Section 2 hereof.

“Warrants” has the meaning
ascribed to such term in the recitals of this Agreement.

2. 

Term.  The term (the “
Term”) of this Agreement shall commence on the Effective Date and terminate on the earlier of: (i) the date that the
Warrants are no longer exercisable and (ii) the date on which all shares of Registrable Securities held or entitled to be held upon
exercise of the Warrants by the Holders are eligible to be sold under Rule 144.

 

3. 

Registration.

 

(a)

Piggyback Registration.  If at
any time during the Term of this Agreement, the Company proposes to register for sale for cash any of its Common Stock, for its own
account or for the account of others (other than the Holders), under the Securities Act on any form for registration thereunder (the
“Registration Statement”), other than (i) a registration relating solely to employee benefit plans or securities
issued or issuable to employees, consultants (to the extent the securities owned or to be owned by such consultants could be
registered on Form S-8) or any of their Family Members (including a registration on Form S-8) or (ii) a registration relating solely
to a Securities Act Rule 145 transaction or a registration on Form S-4 in connection with a merger, acquisition, divestiture,
reorganization or similar event, the Company shall promptly (and in no event less than twenty (20) calendar days prior to the filing
of such Registration Statement) give written notice thereof to the Holders (the “Company Notice”).  If a 

3

Holder wishes to include any Registrable Securities as a
Piggyback Registration in the subject Registration Statement, such Holder shall provide written notice to the Company specifying the
number of Registrable Securities desired to be included (an “Inclusion Notice”) within ten (10) calendar days of
the date of the Company Notice (the “Inclusion Period”).  Provided that, during the Inclusion Period, the
Company receives Inclusion Notices requesting the Piggyback Registration of at least a majority of the Registrable Securities, the
Company shall include as a Piggyback Registration all of the Registrable Securities specified in the Inclusion Notices.
 Notwithstanding the foregoing, the Company may, without the consent of any of the Holders, withdraw such Registration
Statement prior to its becoming effective if the Company or such other shareholders have elected to abandon the proposal to register
the securities proposed to be registered thereby.  The Company shall be obligated to file and cause the effectiveness of only
one (1) Piggyback Registration.  

 

(b)

Underwriting.  If a Piggyback
Registration is for a registered public offering that is to be made by an underwriting, the Company shall, in the Company Notice, so
advise the Holders of the Registrable Securities eligible for inclusion in such Registration Statement pursuant to Section 3(a). In
such event, in addition to the conditions set forth in Section 3(a), the right of any Holder to Piggyback Registration shall be
conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable
Securities in the underwriting to the extent provided herein. All Holders proposing to sell any of their Registrable Securities
through such underwriting shall (together with the Company and any other shareholders of the Company selling their securities
through such underwriting) enter into an underwriting agreement in customary form with the underwriter selected for such
underwriting by the Company or the selling shareholders, as applicable. Notwithstanding any other provision of this Section 3, if
the underwriter or the Company determines that marketing factors require a limitation on the number of shares of Common Stock or the
amount of other securities to be underwritten, the underwriter may exclude some or all of the Registrable Securities from such
registration and underwriting. The Company shall so advise all Holders (except those Holders who failed to timely elect to include
their Registrable Securities through such underwriting or have indicated to the Company their decision not to do so), and indicate
to each such Holder the number of shares of Registrable Securities that may be included in the registration and underwriting, if
any.  The number of shares that may be included in the registration and underwriting shall be allocated first to the Company
and then, subject to obligations and commitments existing as of the date hereof, to all selling shareholders,
including the Holders, who have requested to sell in the registration on a pro rata basis according to the number of shares
requested to be included therein.  In the event that the underwriter or Company determines to exclude more than 50.0% of the
Registrable Securities from the registration and underwriting in accordance with this Section 3(b), such registration and
underwriting shall not be deemed to be a Piggyback Registration for purposes of the last sentence of Section 3(a) above. 

No Registrable Securities excluded from the underwriting by
reason of the underwriter’s marketing limitation shall be included in such registration. If any Holder disapproves of the terms
of any such underwriting, such Holder may elect to withdraw such Holder’s Registrable Securities therefrom by delivering a
written notice to the Company and the underwriter. The Registrable Securities so withdrawn from such underwriting shall also be
withdrawn from such registration; provided, however, that, if by the withdrawal of such Registrable Securities, a
greater number of Registrable Securities held by other Holders may be included in such registration (up to the maximum of any
limitation imposed by the underwriters), then the Company shall offer to all Holders who have included Registrable Securities in the
registration the right to include additional Registrable Securities pursuant to the terms and limitations set forth herein in the
same proportion used above in determining the underwriter limitation. 

4. 

Registration Procedures
  The Company will keep each Holder who has delivered an Inclusion Notice reasonably advised as to the filing and
effectiveness of the Registration Statement. At its expense with respect to the Registration Statement, the Company will:

4

(a)

use its commercially reasonable efforts to
cause such Registration Statement to become effective and remain effective for a period of six (6) months or for such shorter period
ending on the earlier to occur of (i) the sale of all Registrable Common Shares and (ii) the availability under Rule 144 for the
Holders to sell all of the Registrable Common Shares in any ninety (90) day period (the “Effectiveness Period”). Each Holder agrees to furnish to the Company a completed questionnaire in the form provided by the Company (a “
Selling Shareholder Questionnaire”) not later than three (3) Business Days following the date on which such Holder
receives draft materials of such Registration Statement;

(b)

if the Registration Statement is subject to
review by the Commission, promptly respond to all comments and diligently pursue resolution of any comments to the satisfaction of
the Commission;

 

(c)

prepare and file with the Commission such
amendments and supplements to such Registration Statement as may be necessary to keep such Registration Statement effective during
the Effectiveness Period;

 

(d)

furnish, without charge, to each Holder of
Registrable Common Shares covered by such Registration Statement (i) such number of copies of such Registration Statement (including
any exhibits thereto other than exhibits incorporated by reference) and each amendment and supplement thereto, as such Holder may
reasonably request, (ii) such number of copies of the prospectus included in such Registration Statement (including each preliminary
prospectus and any other prospectus filed under Rule 424 of the Securities Act) as such Holder may reasonably request, in conformity
with the requirements of the Securities Act, and (iii) such other documents as such Holder may require to consummate the disposition
of the Registrable Common Shares owned by such Holder, but only during the Effectiveness Period;

 

(e)

use its commercially reasonable efforts to
register or qualify such registration under such other applicable securities laws of such jurisdictions as any Holder of Registrable
Common Shares covered by such Registration Statement reasonably requests and as may be necessary for the marketability of the
Registrable Common Shares (such request to be made by the time the applicable Registration Statement is deemed effective by the
Commission) and do any and all other acts and things necessary to enable such Holder to consummate the disposition in such
jurisdictions of the Registrable Common Shares owned by such Holder; provided, that the Company shall not be required to (i)
qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this paragraph,
(ii) subject itself to taxation in any such jurisdiction, or (iii) consent to general service of process in any such jurisdiction;

 

(f)

at any time during the period commencing on
the filing of the Registration Statement and ending on the last day of the Effectiveness Period, notify each Holder of Registrable
Common Shares covered by such Registration Statement, as promptly as practicable after becoming aware of such event, of the
happening of any event, which comes to the Company’s attention, that will after the occurrence of such event cause the
prospectus included in such Registration Statement, if not amended or supplemented, to contain an untrue statement of a material
fact or an omission to state a material fact required to be stated therein or necessary to make the statements therein not
misleading.  In such event, the Company shall promptly thereafter prepare and furnish to such Holder a supplement or amendment
to such prospectus (or prepare and file appropriate reports under the Exchange Act) so that, as thereafter delivered to the
purchasers of such Registrable Common Shares, such prospectus shall not contain an untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein not misleading, unless suspension
of the use of such prospectus otherwise is authorized herein or in the event of a Blackout Period, in which case no supplement or
amendment need be furnished (or Exchange Act filing made) until the termination of such suspension or Blackout Period; 

5

(g)

use its reasonable best efforts to comply,
and continue to comply during the Effectiveness Period, in all material respects with the Securities Act and the Exchange Act and
with all applicable rules and regulations of the Commission with respect to the disposition of all securities covered by such
Registration Statement;

 

(h)

as promptly as practicable after becoming
aware of such event, notify each Holder of Registrable Common Shares being offered or sold pursuant to the Registration Statement of
the issuance by the Commission of any stop order or other suspension of effectiveness of the Registration Statement;

 

(i)

use its commercially reasonable efforts to
cause all the Registrable Common Shares covered by the Registration Statement to be quoted on the NASDAQ Capital Market or such
other principal securities market on which securities of the same class or series issued by the Company are then listed or traded;

 

(j)

provide a transfer agent and registrar,
which may be a single entity, for the shares of Common Stock at all times;

 

(k)

cooperate with the Holders of Registrable
Common Shares being offered pursuant to the Registration Statement to issue and deliver, or cause its transfer agent to issue and
deliver, certificates representing Registrable Common Shares to be offered pursuant to the Registration Statement within a
reasonable time after the delivery of certificates representing the Registrable Common Shares to the transfer agent or the Company,
as applicable, and enable such certificates to be in such denominations or amounts as the Holders may reasonably request and
registered in such names as the Holders may request; and

 

(l)

during the Effectiveness Period, refrain
from bidding for or purchasing any Common Stock or any right to purchase Common Stock or attempting to induce any person to purchase
any such security or right if such bid, purchase or attempt would in any way limit the right of the Holders to sell Registrable
Common Shares by reason of the limitations set forth in Regulation M of the Exchange Act.

 

5. 

Suspension of Offers and Sales.
 Each Holder agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in
Section 4(f) hereof or of the commencement of a Blackout Period, such Holder shall discontinue the disposition of Registrable Common
Shares included in the Registration Statement until such Holder’s receipt of the copies of the supplemented or amended
prospectus contemplated by Section 4(f) hereof or notice of the end of the Blackout Period, and, if so directed by the Company, such
Holder shall deliver to the Company (at the Company’s expense) all copies (including, without limitation, any and all drafts),
other than permanent file copies, then in such Holder’s possession, of the prospectus covering such Registrable Common Shares
current at the time of receipt of such notice.

6. 

Registration Expenses. The Company
shall pay all expenses in connection with any registration obligation provided herein, including, without limitation, all
registration, filing, stock exchange fees, printing expenses, all fees and expenses of complying with applicable securities laws,
and the fees and disbursements of counsel for the Company and of its independent accountants; provided, that, in any
underwritten registration, each party shall pay for its own underwriting discounts and commissions and transfer taxes. Except as
provided in this Section and Section 9, the Company shall not be responsible for the expenses of any attorney or other advisor
employed by a Holder.

 

7. 

Assignment of Rights. No Holder may
assign its rights under this Agreement to any party without the prior written consent of the Company; provided, however, that any Holder may assign its rights under 

6

this Agreement without such consent to a Permitted Assignee as
long as (a) such transfer or assignment is effected in accordance with applicable securities laws; (b) such transferee or assignee
agrees in writing to become subject to the terms of this Agreement; (c) such transfer or assignment is effected in accordance with
the Warrant Agreement evidencing the Warrants; and (d) such Holder notifies the Company in writing of such transfer or assignment,
stating the name and address of the transferee or assignee and identifying the Registrable Securities with respect to which such
rights are being transferred or assigned.

 

8. 

Information by Holder. Holders
included in any registration shall furnish to the Company such information as the Company may reasonably request in writing
regarding such Holders and the distribution proposed by such Holders including an updated Selling Shareholder Questionnaire if
requested by the Company.

 

9. 

Indemnification.

 

(a)

In the event of the offer and sale of
Registrable Securities under the Securities Act, the Company shall, and hereby does, indemnify and hold harmless, to the fullest
extent permitted by law, each Holder, its directors, officers, partners, each other person who participates as an underwriter in the
offering or sale of such securities, and each other person, if any, who controls or is under common control with such Holder or any
such underwriter within the meaning of Section 15 of the Securities Act, against any losses, claims, damages or liabilities, joint
or several, and expenses to which the Holder or any such director, officer, partner or underwriter or controlling person may become
subject under the Securities Act or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions or
proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon any untrue statement of any
material fact contained in any registration statement prepared and filed by the Company under which Registrable Securities were
registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus contained therein, or any
amendment or supplement thereto, or any omission to state therein a material fact required to be stated or necessary to make the
statements therein in light of the circumstances in which they were made not misleading, and the Company shall reimburse the Holder,
and each such director, officer, partner, underwriter and controlling person for any legal or any other expenses reasonably incurred
by them in connection with investigating, defending or settling any such loss, claim, damage, liability, action or proceeding;
provided, that such indemnity agreement found in this Section 9(a) shall in no event exceed the net proceeds from the Sale of
securities, received by the Company; and provided further, that the Company shall not be
liable in any such case (i) to the extent that any such loss, claim, damage, liability (or action or proceeding in respect thereof)
or expense arises out of or is based upon an untrue statement in or omission from such registration statement, any such preliminary
prospectus, final prospectus, summary prospectus, amendment or supplement in reliance upon and in conformity with written
information furnished to the Company by a Holder for use in the preparation thereof or (ii) if the person asserting any such loss,
claim, damage, liability (or action or proceeding in respect thereof) who purchased the Registrable Securities that are the subject
thereof did not receive a copy of an amended preliminary prospectus or the final prospectus (or the final prospectus as amended or
supplemented) at or prior to the written confirmation of the sale of such Registrable Securities to such person because of the
failure of such Holder or underwriter to so provide such amended preliminary or final prospectus and the untrue statement or
omission of a material fact made in such preliminary prospectus was corrected in the amended preliminary or final prospectus (or the
final prospectus as amended or supplemented). Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of the Holders, or any such director, officer, partner, underwriter or controlling person and shall survive the
transfer of such shares by the Holder.

(b)

As a condition to including Registrable
Securities in any registration statement filed pursuant to this Agreement, each Holder agrees to be bound by the terms of this
Section 9 and to indemnify and hold harmless, to the fullest extent permitted by law, the Company, each of its directors,

7

officers, partners, legal counsel and accountants and each
underwriter, if any, and each other person, if any, who controls the Company within the meaning of Section 15 of the Securities Act,
against any losses, claims, damages or liabilities, joint or several, to which the Company or any such director or officer or
controlling person may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities
(or actions or proceedings, whether commenced or threatened, in respect thereof) that arises out of or is based upon an untrue
statement in or omission from such registration statement, any such preliminary prospectus, final prospectus, summary prospectus,
amendment or supplement in reliance upon and in conformity with written information furnished by the Holder for use in the
preparation thereof, and such Holder shall reimburse the Company, and such Holders, directors, officers, partners, legal counsel and
accountants, persons, underwriters, or control persons, each such director, officer, and controlling person for any legal or other
expenses reasonably incurred by them in connection with investigating, defending, or settling any such loss, claim, damage,
liability, action, or proceeding; provided, however, that such indemnity agreement found in this Section 9(b) shall in
no event exceed the net proceeds received by such Holder as a result of the sale of Registrable Securities pursuant to such
registration statement, except in the case of fraud or willful misconduct. Such indemnity shall remain in full force and effect,
regardless of any investigation made by or on behalf of the Company or any such director, officer or controlling person and shall
survive the transfer by any Holder of such shares.

(c)

Promptly after receipt by an indemnified
party of notice of the commencement of any action or proceeding involving a claim referred to in this Section (including any
governmental action), such indemnified party shall, if a claim in respect thereof is to be made against an indemnifying party, give
written notice to the indemnifying party of the commencement of such action; provided, that the failure of any indemnified
party to give notice as provided herein shall not relieve the indemnifying party of its obligations under this Section, except to
the extent that the indemnifying party is actually prejudiced by such failure to give notice. In case any such action is brought
against an indemnified party, unless in the reasonable judgment of counsel to such indemnified party a conflict of interest between
such indemnified and indemnifying parties may exist or the indemnified party may have defenses not available to the indemnifying
party in respect of such claim, the indemnifying party shall be entitled to participate in and to assume the defense thereof, with
counsel reasonably satisfactory to such indemnified party and, after notice from the indemnifying party to such indemnified party of
its election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party for any legal or
other expenses subsequently incurred by the latter in connection with the defense thereof, unless in such indemnified party’s
reasonable judgment a conflict of interest between such indemnified and indemnifying parties arises in respect of such claim after
the assumption of the defenses thereof or the indemnifying party fails to defend such claim in a diligent manner, other than
reasonable costs of investigation. Neither an indemnified nor an indemnifying party shall be liable for any settlement of any action
or proceeding effected without its consent. No indemnifying party shall, without the consent
of the indemnified party, consent to entry of any judgment or enter into any settlement, which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect of such
claim or litigation. Notwithstanding anything to the contrary set forth herein, and without limiting any of the rights set forth
above, in any event any party shall have the right to retain, at its own expense, counsel with respect to the defense of a claim.
Each indemnified party shall furnish such information regarding itself or the claim in question as an indemnifying party may
reasonably request in writing and as shall be reasonably required in connection with defense of such claim and litigation resulting
therefrom.

 

(d)

If an indemnifying party does or is not
permitted to assume the defense of an action pursuant to Sections 9(c) or in the case of the expense reimbursement obligation set
forth in Sections 9(a) and (b), the indemnification required by Sections 9(a) and 9(b) shall be made by periodic payments of the
amount thereof during the course of the investigation or defense, as and when bills received or expenses, 

8

losses, damages, or liabilities are incurred.

 

(e)

If the indemnification provided for in
Section 9(a) or 9(b) is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any
loss, liability, claim, damage or expense referred to herein, the indemnifying party, in lieu of indemnifying such indemnified party
hereunder, shall (i) contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim,
damage or expense as is appropriate to reflect the proportionate relative fault of the indemnifying party on the one hand and the
indemnified party on the other (determined by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or omission relates to information supplied by the indemnifying party or the indemnified party and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission), or (ii)
if the allocation provided by clause (i) above is not permitted by applicable law or provides a lesser sum to the indemnified party
than the amount hereinafter calculated, not only the proportionate relative fault of the indemnifying party and the indemnified
party, but also the relative benefits received by the indemnifying party on the one hand and the indemnified party on the other, as
well as any other relevant equitable considerations. No indemnified party guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) shall be entitled to contribution from any indemnifying party who was not guilty of such
fraudulent misrepresentation.

(f)

Notwithstanding the foregoing, to the extent
that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with an
underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall
control.

 

(g) 

Indemnification similar to that specified in
this Section (with appropriate modifications) shall be given by the Company and each Holder of Registrable Securities with respect
to any required registration or other qualification of securities under any federal or state law or regulation or governmental
authority other than the Securities Act.

 

10.

Independent Nature of Each
Investor’s Obligations and Rights. The obligations of each Investor under this Agreement are several and not joint with the
obligations of any other Investor, and each Investor shall not be responsible in any way for the performance of the obligations of
any other Investor under this Agreement. Nothing contained herein and no action taken by any Investor pursuant hereto, shall be
deemed to constitute such Investors as a partnership, an association, a joint venture, or any other kind of entity, or create a
presumption that the Investors are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by this Agreement. Each Investor shall be entitled to independently protect and enforce its rights, including without
limitation the rights arising out of this Agreement, and it shall not be necessary for any other Investor to be joined as an
additional party in any proceeding for such purpose.

 

11. 

Miscellaneous.

 

(a)

Governing Law; Jurisdiction.
 The validity and effect of this Agreement, and the rights and obligations of the parties hereto, shall be enforced,
governed by, and construed in all respect in accordance with the internal laws of the State of Florida (without reference to
conflict of laws provisions).  Each Party hereby irrevocably and unconditionally (a) agrees that any Action or Proceeding, at
Law or equity, arising out of or relating to this Agreement and any other agreements or the transactions contemplated hereby and
thereby shall only be brought in the state or federal courts located in Miami-Dade County, Florida, (b) expressly submits to the
personal jurisdiction and venue of such courts for the purposes thereof and (c) waives and agrees not to raise (by way of motion, as
a defense or otherwise) any and all jurisdictional, venue and convenience objections or defenses that such party may have in such

9

action or proceeding.  Each party hereby irrevocably and
unconditionally consents to the service of process of any of the aforementioned courts.  Nothing herein contained shall be
deemed to affect the right of any party to serve process in any manner permitted by law or commence legal proceedings or otherwise
proceed against any other party in any other jurisdiction to enforce judgments obtained in any action or proceeding brought pursuant
to this Section 10(a).

 

(b)

Remedies. In the event of a breach by
the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the Company, as the case may
be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages,
shall be entitled to specific performance of its rights under this Agreement. The Company and each Holder agree that monetary
damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this
Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall
not assert or shall waive the defense that a remedy at law would be adequate.

(c)

Successors and Assigns. Except as
otherwise provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, Permitted
Assignees, executors and administrators of the parties hereto.

 

(d)

No Inconsistent Agreements. The
Company has not entered, as of the date hereof, and shall not enter, on or after the date of this Agreement, into any agreement with
respect to its securities that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise
conflicts with the provisions hereof.

 

(e)

Entire Agreement. This Agreement
constitutes the full and entire understanding and agreement between the parties with regard to the subjects hereof.

 

(f)

Notices, etc.  All notices, requests, demands, and
other communications under this Agreement shall be in writing and shall be deemed to have been duly given on the date of service if
served personally on the party to whom notice is to be given, on the date of transmittal of services via facsimile or telecopy to
the party to whom notice is to be given (if receipt is orally confirmed by phone and a confirming copy delivered thereafter in
accordance with this Section), or on the fifth day after mailing if mailed to the party to whom notice is to be given, by first
class mail, registered or certified, postage prepaid, or via a nationally recognized overnight courier providing a receipt for
delivery and properly addressed to the applicable address as set forth below. Any party may change its address for purposes of this
paragraph by giving notice of the new address to each of the other parties in the manner set forth above.

(a)

If to the Company to:

Bioheart, Inc.

13794 NW 4th Street

Suite 212

Sunrise, Florida 33325

Attention: Corporate Secretary

Fax:       (954) 845-9976

Phone:   (954) 835-1500

10

With a
copy to:

Gregory Sichenzia

Sichenzia Ross Friedman Ference LLP

61 Broadway

32nd Floor

New York, NY 10006

Fax:  ( (212) 930-9725

Phone  (212) 930-9700

(b) If to the Investor, to the Investor’s address
set forth on the signature page hereto.

(g)

Delays or Omissions. No delay or
omission to exercise any right, power or remedy accruing to any Holder, upon any breach or default of the Company under this
Agreement, shall impair any such right, power or remedy of such Holder nor shall it be construed to be a waiver of any such breach
or default, or an acquiescence therein, or of any similar breach or default thereunder occurring; nor shall any waiver of any single
breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent
or approval of any kind or character on the part of any Holder of any breach or default under this Agreement, or any waiver on the
part of any Holder of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent
specifically set forth in such writing. All remedies, either under this Agreement, or by law or otherwise afforded to any holder,
shall be cumulative and not alternative.

(h) 

Counterparts. This Agreement may be
executed in any number of counterparts, each of which shall be enforceable against the parties actually executing such counterparts,
and all of which together shall constitute one instrument. In the event that any signature is delivered by facsimile transmission,
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such facsimile signature page were an original thereof.

 

(i)

 Severability. In the case any
provision of this Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining
provisions shall not in any way be affected or impaired thereby.

 

(j)

Amendments. The provisions of this
Agreement may be amended at any time and from time to time, and particular provisions of this Agreement may be waived, with and only
with an agreement or consent in writing signed by the Company and the Majority of the Holders. The Investors acknowledge that by the
operation of this Section, the Majority Holders may have the right and power to diminish or eliminate all rights of the Investors
under this Agreement.

(k)

Waiver of Jury Trial.  
EACH INVESTOR AND THE COMPANY HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING BASED UPON, OR
RELATED TO, THE SUBJECT MATTER OF THIS LETTER AGREEMENT. THIS WAIVER IS KNOWINGLY, INTENTIONALLY AND VOLUNTARILY MADE BY SUCH
INVESTOR AND THE COMPANY.

[SIGNATURE PAGES FOLLOW]

11

PAGE INTENTIONALLY LEFT BLANK

12

This Registration Rights Agreement is hereby executed as of
the date first above written.

THE COMPANY

By: __________________________

Name: Mike Tomas

Title: Chief Executive Officer & President

 

[SIGNATURE PAGE OF INVESTOR FOLLOWS]

13

PAGE INTENTIONALLY LEFT BLANK

14

This Registration Rights Agreement is hereby executed as of the date first
above written.

 

					
	INVESTOR (Individual(s))

	 

	  

	  

	  

	 

	 By: 

	 

	 

	 

	 
	 
	 
	 

	  Print Name(s):
  

	  

	  

	 

	 

	 

	 

	 

	 

	 

	 

	 

	INVESTOR(Entity)
  

	 

	 

	 

	By: 

	  

	  

	 

	 
	 
	 
	 

	Print Name:

	 

	 

	 

	 
	 
	 
	 

	Print Title:

	   

	  

	 

	 

	 

	 

	 

	Address for notices:

	 

	 

	 

	 

	 

	 
	
  

	  

	 

	 
	 
	 
	 

	  

	 
	
 

	 

	 
	 
	 
	 

	  

	
  

	  

	 

	 
	 
	 
	 

	 

	
 

	 

	 

	  

	  

	  

	 

	 
	 
	 
	 

 

15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}]]